- Home
- IHRT vs MNPR Comparison
IHRT vs MNPR Comparison
Compare IHRT & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- MNPR
- Stock Information
- Founded
- IHRT 1974
- MNPR 2014
- Country
- IHRT United States
- MNPR United States
- Employees
- IHRT N/A
- MNPR N/A
- Industry
- IHRT Broadcasting
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- MNPR Health Care
- Exchange
- IHRT Nasdaq
- MNPR Nasdaq
- Market Cap
- IHRT 292.3M
- MNPR 248.8M
- IPO Year
- IHRT 2019
- MNPR 2019
- Fundamental
- Price
- IHRT $2.25
- MNPR $35.71
- Analyst Decision
- IHRT Buy
- MNPR Strong Buy
- Analyst Count
- IHRT 3
- MNPR 7
- Target Price
- IHRT $2.92
- MNPR $62.00
- AVG Volume (30 Days)
- IHRT 904.7K
- MNPR 20.7K
- Earning Date
- IHRT 08-11-2025
- MNPR 08-12-2025
- Dividend Yield
- IHRT N/A
- MNPR N/A
- EPS Growth
- IHRT N/A
- MNPR N/A
- EPS
- IHRT N/A
- MNPR N/A
- Revenue
- IHRT $3,867,156,000.00
- MNPR N/A
- Revenue This Year
- IHRT N/A
- MNPR N/A
- Revenue Next Year
- IHRT $5.89
- MNPR N/A
- P/E Ratio
- IHRT N/A
- MNPR N/A
- Revenue Growth
- IHRT 3.18
- MNPR N/A
- 52 Week Low
- IHRT $0.95
- MNPR $2.15
- 52 Week High
- IHRT $2.84
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- IHRT 68.68
- MNPR 43.81
- Support Level
- IHRT $1.54
- MNPR $30.51
- Resistance Level
- IHRT $2.29
- MNPR $36.51
- Average True Range (ATR)
- IHRT 0.17
- MNPR 3.33
- MACD
- IHRT 0.05
- MNPR -0.95
- Stochastic Oscillator
- IHRT 80.23
- MNPR 37.55
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.